Respiratory Investigation

Scope & Guideline

Advancing knowledge in Pulmonary and Respiratory Medicine.

Introduction

Explore the comprehensive scope of Respiratory Investigation through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Respiratory Investigation in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2212-5345
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2012 to 2024
AbbreviationRESPIR INVESTIG / Respir. Investig.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal "Respiratory Investigation" aims to advance the understanding of respiratory diseases through comprehensive research that encompasses clinical practice, epidemiology, and innovative treatment strategies. Its scope includes a wide range of topics related to respiratory health, with a strong emphasis on both basic and applied research.
  1. Clinical Research on Respiratory Diseases:
    The journal publishes studies focused on the clinical aspects of respiratory diseases, including epidemiology, diagnosis, treatment, and management strategies. This encompasses a variety of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and interstitial lung diseases.
  2. Innovative Therapeutic Approaches:
    Research on novel therapeutic agents and treatment modalities for respiratory diseases is a core focus. This includes studies on immunotherapy, targeted therapies, and the use of biologics in managing complex respiratory conditions.
  3. Diagnostic Advancements:
    The journal covers advancements in diagnostic techniques, including imaging, biomarkers, and new methodologies for assessing respiratory function and disease progression, which contribute to better clinical outcomes.
  4. Epidemiological Studies:
    Epidemiological research is a significant component, focusing on the prevalence, risk factors, and outcomes associated with respiratory diseases, particularly in specific populations or regions.
  5. Translational Research:
    The journal emphasizes studies that bridge laboratory research and clinical practice, aiming to translate findings into actionable strategies for improving patient care in respiratory medicine.
The journal has reflected significant trends and emerging themes in respiratory research, highlighting the dynamic nature of the field as it responds to new challenges and scientific advancements. Recent publications indicate a strong focus on innovative treatment strategies and the implications of ongoing global health issues.
  1. Impact of COVID-19 on Respiratory Health:
    Research related to the effects of COVID-19 on respiratory health continues to gain prominence, encompassing studies on long COVID, post-viral syndromes, and the implications for patients with pre-existing respiratory conditions.
  2. Personalized Medicine and Biomarkers:
    There is an increasing trend towards personalized medicine, with a focus on identifying biomarkers for disease progression and treatment response, particularly in lung cancer and interstitial lung diseases.
  3. Multidisciplinary Approaches to Respiratory Disease Management:
    Emerging themes emphasize the importance of multidisciplinary approaches to managing respiratory diseases, integrating insights from various specialties to improve patient outcomes.
  4. Telemedicine and Remote Monitoring:
    The rise of telemedicine and digital health technologies is reflected in the journal's publications, focusing on their role in monitoring and managing respiratory conditions, especially during and after the pandemic.
  5. Environmental and Occupational Health:
    Research addressing the impact of environmental and occupational factors on respiratory health is increasingly relevant, reflecting broader public health concerns and the need for preventive strategies.

Declining or Waning

While "Respiratory Investigation" continues to evolve, certain themes have seen a decline in focus over recent years. This may reflect shifting priorities in research funding, emerging health challenges, or advancements that have rendered some areas less critical.
  1. Traditional Antibiotic Treatments:
    There is a noticeable decrease in studies focusing solely on traditional antibiotic treatments for respiratory infections, as the field shifts towards exploring personalized medicine and alternative therapeutic approaches.
  2. Basic Science of Respiratory Physiology:
    Research articles dedicated to the basic science of respiratory physiology have reduced in number, possibly due to a growing emphasis on clinical and translational research that directly impacts patient care.
  3. Single-Disease Focus Studies:
    Research that focuses exclusively on single diseases, such as isolated asthma or COPD, appears to be waning in favor of studies that explore comorbidities and the interconnectedness of multiple respiratory conditions.
  4. Historical Perspectives on Respiratory Diseases:
    There seems to be a decreasing interest in publishing articles that provide historical perspectives or reviews of past treatment modalities, as the focus shifts towards contemporary challenges and future directions.

Similar Journals

Multidisciplinary Respiratory Medicine

Elevating knowledge and practice in pulmonary medicine.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

LUNG

Innovating the future of pulmonary medicine with every publication.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

Thoracic Research and Practice

Transforming Knowledge into Practice for Better Lung Health
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

Lung India

Pioneering the future of respiratory research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

Annals of the American Thoracic Society

Pioneering the path in pulmonary and respiratory advancements.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Egyptian Journal of Chest Diseases and Tuberculosis

Exploring breakthroughs in chest diseases and tuberculosis management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

EUROPEAN RESPIRATORY JOURNAL

Fostering Excellence in Respiratory Research
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Pioneering Open Access for Global Medical Advancement
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

CHEST

Elevating the standards of pulmonary medicine research.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

REVUE DES MALADIES RESPIRATOIRES

Fostering discussions that shape respiratory care.
Publisher: MASSON EDITEURISSN: 0761-8425Frequency: 10 issues/year

REVUE DES MALADIES RESPIRATOIRES is a distinguished journal published by MASSON EDITEUR, focusing on the vital field of pulmonary and respiratory medicine. Established in 1984, this journal has become a prominent platform for sharing innovative research and clinical findings, reflecting an impressive array of studies that contribute to our understanding of respiratory diseases. With its ISSN 0761-8425 and E-ISSN 1776-2588, it facilitates access to scholarly work within the medical community, although it currently operates under a subscription model rather than Open Access. As indicated by its quartile ranking of Q4 in 2023 within its category and a Scopus rank of #128/155, REVUE DES MALADIES RESPIRATOIRES serves as an essential resource for researchers, professionals, and students aiming to stay informed about advancements in respiratory health. This journal plays a crucial role in fostering discussions that drive innovation and best practices in the treatment and understanding of respiratory conditions.